BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 28704225)

  • 1. Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease.
    Stein RE; Plantz K; Maxwell EC; Mamula P; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2018 Feb; 66(2):e51-e55. PubMed ID: 28704225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease.
    Mamula P; Piccoli DA; Peck SN; Markowitz JE; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):286-90. PubMed ID: 11964953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
    Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark.
    Pollock RF; Muduma G
    Adv Ther; 2018 Dec; 35(12):2128-2137. PubMed ID: 30456520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of parenteral iron in children with inflammatory bowel disease.
    Papadopoulos M; Patel D; Korologou-Linden R; Goto E; Soondrum K; Fell JME; Epstein J
    Br J Clin Pharmacol; 2018 Apr; 84(4):694-699. PubMed ID: 29266387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement.
    Gisbert JP; Bermejo F; Pajares R; Pérez-Calle JL; Rodríguez M; Algaba A; Mancenido N; de la Morena F; Carneros JA; McNicholl AG; González-Lama Y; Maté J
    Inflamm Bowel Dis; 2009 Oct; 15(10):1485-91. PubMed ID: 19408339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
.
    Macdougall IC; Strauss WE; Dahl NV; Bernard K; Li Z
    Clin Nephrol; 2019 Apr; 91(4):237-245. PubMed ID: 30802204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease.
    Aksan A; Işık H; Radeke HH; Dignass A; Stein J
    Aliment Pharmacol Ther; 2017 May; 45(10):1303-1318. PubMed ID: 28326596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of intravenous iron sucrose in children younger than 2 years with intestinal failure.
    Lepus CA; Samela K; Mokha JS
    Nutr Clin Pract; 2023 Aug; 38(4):899-903. PubMed ID: 36440796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010-2014.
    Akhuemonkhan E; Parian A; Carson KA; Hutfless S
    Inflamm Bowel Dis; 2018 Jul; 24(8):1801-1807. PubMed ID: 29669068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study.
    Valério de Azevedo S; Maltez C; Lopes AI
    Scand J Gastroenterol; 2017 Jan; 52(1):29-33. PubMed ID: 27576956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials.
    Naqash A; Ara R; Bader GN
    BMC Womens Health; 2018 Jan; 18(1):6. PubMed ID: 29304848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Iron Sucrose for Children With Iron Deficiency Anemia.
    Kaneva K; Chow E; Rosenfield CG; Kelly MJ
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e259-e262. PubMed ID: 28562517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of Iron Deficiency Anemia With Intravenous Iron Sucrose in Children With Inflammatory Bowel Disease.
    Danko I; Weidkamp M
    J Pediatr Gastroenterol Nutr; 2016 Nov; 63(5):e107-e111. PubMed ID: 27540710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study.
    Ikuta K; Hanashi H; Hirai K; Ota Y; Matsuyama Y; Shimura A; Terauchi M; Momoeda M
    Int J Hematol; 2019 Jan; 109(1):41-49. PubMed ID: 30039442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice.
    Stein J; Walper A; Klemm W; Farrag K; Aksan A; Dignass A
    Scand J Gastroenterol; 2018 Sep; 53(9):1059-1065. PubMed ID: 30222479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Anemia, Iron, Therapy, and Transfusion in Hospitalized Pediatric Patients with Inflammatory Bowel Disease.
    Jacobson-Kelly AE; Stanek JR; Powers JM; Dotson JL; O'Brien SH
    J Pediatr; 2020 Jul; 222():141-145.e1. PubMed ID: 32444225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.
    Evstatiev R; Marteau P; Iqbal T; Khalif IL; Stein J; Bokemeyer B; Chopey IV; Gutzwiller FS; Riopel L; Gasche C;
    Gastroenterology; 2011 Sep; 141(3):846-853.e1-2. PubMed ID: 21699794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of iron deficiency anemia and iron deficiency in a pediatric population with inflammatory bowel disease.
    Carvalho FSG; de Medeiros IA; Antunes H
    Scand J Gastroenterol; 2017 Oct; 52(10):1099-1103. PubMed ID: 28643539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23.
    Dahlerup JF; Jacobsen BA; van der Woude J; Bark LÅ; Thomsen LL; Lindgren S
    Scand J Gastroenterol; 2016 Nov; 51(11):1332-8. PubMed ID: 27326766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.